Study: NCT02329730

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 14 at risk

Adverse event: Pain at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 14 at risk

Adverse event: Pain at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 14 at risk

Adverse event: High blood pressure
Serious: no
Organ System: Vascular disorders
Frequency: 2 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 1 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 1 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 14 at risk

Adverse event: Pain at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 14 at risk

Adverse event: Pain at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 14 at risk

Adverse event: Phlebitis
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 1 affected / 14 at risk

Adverse event: Vasculitis
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 14 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 2 affected / 8 at risk

Adverse event: Phlebitis
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 8 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 8 at risk

Adverse event: Pain at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 8 at risk

Adverse event: Vasculitis
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 8 at risk

Adverse event: Itching at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Itching at the injection site is the most common adverse events for this clinical trial .And the vast majority of itching is the first level(mild) .
Frequency: 3 affected / 8 at risk

Adverse event: Pain at the injection site
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 8 at risk

Adverse event: Pyrexia
Serious: no
Organ System: Investigations
Frequency: 1 affected / 8 at risk

Adverse event: Vasculitis
Serious: no
Organ System: Vascular disorders
Frequency: 1 affected / 8 at risk

Adverse event: Percentage abnormal of Eosinophils
Serious: no
Organ System: Blood and lymphatic system disorders
Frequency: 1 affected / 8 at risk